Acetaminophen And Codeine Phosphate
FDA Label NDC 53002-3410

96 label sections · Submitted to the FDA by Rpk Pharmaceuticals, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rpk Pharmaceuticals, Inc. for the product Acetaminophen And Codeine Phosphate (NDC 53002-3410). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding risk of medication errors, addiction, abuse, and misuse, opioid analgesic risk evaluation and mitigation strategy (rems), life-threatening respiratory depression, accidental ingestion, ultra-rapid metabolism of codeine and other risk factors for life-threatening respiratory depression in children, neonatal opioid withdrawal syndrome, interactions with drugs affecting cytochrome p450 isoenzymes, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.